Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Sultan Damgaci"'
Autor:
Bruna Victorasso Jardim-Perassi, Pietro Irrera, Oluwaseyi E. Oluwatola, Dominique Abrahams, Veronica C. Estrella, Bryce Ordway, Samantha R. Byrne, Andrew A. Ojeda, Christopher J. Whelan, Jongphil Kim, Matthew S. Beatty, Sultan Damgaci-Erturk, Dario Livio Longo, Kim J. Gaspar, Gabrielle M. Siegers, Barbara A. Centeno, Justin Y. C. Lau, Shari A. Pilon-Thomas, Arig Ibrahim-Hashim, Robert J. Gillies
Publikováno v:
Biomedicines, Vol 12, Iss 2, p 461 (2024)
Acidosis is an important immunosuppressive mechanism that leads to tumor growth. Therefore, we investigated the neutralization of tumor acidity to improve immunotherapy response. L-DOS47, a new targeted urease immunoconjugate designed to neutralize t
Externí odkaz:
https://doaj.org/article/5a610c872c3d4c0c81b99911fe84d7cd
Publikováno v:
Süleyman Demirel Üniversitesi Fen-Edebiyat Fakültesi Fen Dergisi, Vol 11, Iss 1, Pp 51-60 (2016)
Abstract: Internal organ motions are one of the most significant obstacles for radiotherapy, especially in the case of motions caused by respiratory during the lung irradiation. There is no any consensus about the margin limit given for the target vo
Externí odkaz:
https://doaj.org/article/618af161b6c142099fd64a6b1830c177
Autor:
Bruna Victorasso Jardim-Perassi, Pietro Irrera, Justin Y. C. Lau, Mikalai Budzevich, Christopher J. Whelan, Dominique Abrahams, Epifanio Ruiz, Arig Ibrahim-Hashim, Sultan Damgaci Erturk, Dario Livio Longo, Shari A. Pilon-Thomas, Robert J. Gillies
Publikováno v:
Contrast Media & Molecular Imaging.
The extracellular pH (pHe) of solid tumors is often acidic, as a consequence of the Warburg effect, and an altered metabolic state is often associated with malignancy. It has been shown that acidosis can promote tumor progression; thus, many therapeu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5207b877117ba03f70fe08f80f10d80b
Autor:
Robert A. Gatenby, Joel S. Brown, Marilyn M. Bui, Sultan Damgaci, Pedro M. Enriquez-Navas, Jiqiang Yao, Dominique Abrahams, Arig Ibrahim-Hashim, Luddy K, Cliona O'Farrelly, Christina L. Richards, Tingan Chen, Robert J. Gillies
Publikováno v:
British Journal of Cancer
Background Cancer progression is governed by evolutionary dynamics in both the tumour population and its host. Since cancers die with the host, each new population of cancer cells must reinvent strategies to overcome the host’s heritable defences.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6815043bce83b934e9808f5096dccfbb
https://doi.org/10.1038/s41416-020-01110-1
https://doi.org/10.1038/s41416-020-01110-1
Autor:
Jardim-Perassi, Bruna Victorasso, Irrera, Pietro, Lau, Justin Y. C., Budzevich, Mikalai, Whelan, Christopher J., Abrahams, Dominique, Ruiz, Epifanio, Ibrahim-Hashim, Arig, Erturk, Sultan Damgaci, Longo, Dario Livio, Pilon-Thomas, Shari A., Gillies, Robert J.
Publikováno v:
Contrast Media & Molecular Imaging; 1/5/2023, p1-12, 12p
Autor:
Robert J. Gillies, Pedro M. Enriquez-Navas, Sultan Damgaci, Arig Ibrahim-Hashim, Shari Pilon-Thomas, Albert Guvenis
Publikováno v:
Eur J Clin Nutr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::badf544e057a6a8f132f6a675ec2dd89
https://pubmed.ncbi.nlm.nih.gov/32873950
https://pubmed.ncbi.nlm.nih.gov/32873950
Autor:
Sultan Damgaci, Robert J. Gillies, Arig Ibrahim-Hashim, Pedro M. Enriquez-Navas, Shari Pilon-Thomas, Albert Guvenis
Due to imbalances between vascularity and cellular growth patterns, the tumour microenvironment harbours multiple metabolic stressors including hypoxia and acidosis, which have significant influences on remodelling both tumour and peritumoral tissues
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::480f86dbb90f1033f048ebbb380e2e5a
https://europepmc.org/articles/PMC6002221/
https://europepmc.org/articles/PMC6002221/
Autor:
Ghassan El-Haddad, Matthew N. Mills, Sultan Damgaci, Mayer Fishman, Johnna Smith, Jingsong Zhang, Catherine Doyle
Publikováno v:
Journal of Clinical Oncology. 37:312-312
312 Background: Radium-223 dichloride (Xofigo) is an FDA-approved radionuclide used to treat symptomatic bone metastases in patients with castration-resistant prostate cancer (CRPC) with no known visceral metastases. Outside of clinical trial, the be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a2b3e174b0d13f5841e3bdc3c87b9c24
https://doi.org/10.1200/jco.2019.37.7_suppl.312
https://doi.org/10.1200/jco.2019.37.7_suppl.312